Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 May;60(5):1941–1945. doi: 10.1128/iai.60.5.1941-1945.1992

Colchicine prevents tumor necrosis factor-induced toxicity in vivo.

G Tiegs 1, M A Freudenberg 1, C Galanos 1, A Wendel 1
PMCID: PMC257098  PMID: 1563785

Abstract

Tumor necrosis factor (TNF) toxicity was induced in vivo by intravenous administration of 15 micrograms of recombinant murine TNF-alpha per kg to galactosamine-sensitized mice. Within 8 h, the animals developed a fulminant hepatitis. Intravenous administration of 0.5 mg of colchicine per kg at 19 and 4 h prior to TNF challenge protected the animals against hepatitis. Lipopolysaccharide (LPS)-stimulated, bone marrow-derived macrophages from C3H/HeN mice released significant amounts of TNF in vitro. When such macrophages were intravenously given to LPS-resistant galactosamine-sensitized C3H/HeJ mice, these animals died within 24 h. Preincubation of these transferred macrophages with colchicine did not suppress the LPS-inducible TNF release from these cells. Concordantly, administration of macrophages exposed to colchicine in vitro resulted in full lethality. However, in vivo pretreatment of C3H/HeJ mice with colchicine 19 and 4 h prior to the transfer of LPS-stimulated macrophages prevented lethality. In LPS-responsive NMRI mice which had been protected against galactosamine-LPS-induced hepatitis by pretreatment with colchicine, TNF was still released into the blood. We conclude from our findings that the in vivo protection by colchicine is mediated by blocking TNF action on target cells while the effector cells of LPS toxicity, i.e., the macrophages, remain responsive.

Full text

PDF
1941

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baglioni C., McCandless S., Tavernier J., Fiers W. Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J Biol Chem. 1985 Nov 5;260(25):13395–13397. [PubMed] [Google Scholar]
  2. Beutler B., Milsark I. W., Cerami A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985 Aug 30;229(4716):869–871. doi: 10.1126/science.3895437. [DOI] [PubMed] [Google Scholar]
  3. Cooper J. A. Effects of cytochalasin and phalloidin on actin. J Cell Biol. 1987 Oct;105(4):1473–1478. doi: 10.1083/jcb.105.4.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Decker K., Keppler D., Rudigier J., Domschke W. Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis. Hoppe Seylers Z Physiol Chem. 1971 Mar;352(3):412–418. doi: 10.1515/bchm2.1971.352.1.412. [DOI] [PubMed] [Google Scholar]
  5. Ding A. H., Porteu F., Sanchez E., Nathan C. F. Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J Exp Med. 1990 Mar 1;171(3):715–727. doi: 10.1084/jem.171.3.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ding A. H., Porteu F., Sanchez E., Nathan C. F. Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science. 1990 Apr 20;248(4953):370–372. doi: 10.1126/science.1970196. [DOI] [PubMed] [Google Scholar]
  7. Espevik T., Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986 Dec 4;95(1):99–105. doi: 10.1016/0022-1759(86)90322-4. [DOI] [PubMed] [Google Scholar]
  8. Flesch I., Ecker B., Ferber E. Acyltransferase-catalyzed cleavage of arachidonic acid from phospholipids and transfer to lysophosphatides in macrophages derived from bone marrow. Comparison of different donor- and acceptor substrate combinations. Eur J Biochem. 1984 Mar 15;139(3):431–437. doi: 10.1111/j.1432-1033.1984.tb08023.x. [DOI] [PubMed] [Google Scholar]
  9. Fraker D. L., Stovroff M. C., Merino M. J., Norton J. A. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med. 1988 Jul 1;168(1):95–105. doi: 10.1084/jem.168.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Freudenberg M. A., Keppler D., Galanos C. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun. 1986 Mar;51(3):891–895. doi: 10.1128/iai.51.3.891-895.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Galanos C., Freudenberg M. A., Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5939–5943. doi: 10.1073/pnas.76.11.5939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Galanos C., Lüderitz O., Westphal O. Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Orig A. 1979 Apr;243(2-3):226–244. [PubMed] [Google Scholar]
  13. Keppler D., Hagmann W., Rapp S., Denzlinger C., Koch H. K. The relation of leukotrienes to liver injury. Hepatology. 1985 Sep-Oct;5(5):883–891. doi: 10.1002/hep.1840050530. [DOI] [PubMed] [Google Scholar]
  14. Kull F. C., Jr, Cuatrecasas P. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. Cancer Res. 1981 Dec;41(12 Pt 1):4885–4890. [PubMed] [Google Scholar]
  15. Lehmann V., Freudenberg M. A., Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med. 1987 Mar 1;165(3):657–663. doi: 10.1084/jem.165.3.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Neihörster M., Inoue M., Wendel A. A link between extracellular reactive oxygen and endotoxin-induced release of tumour necrosis factor alpha in vivo. Biochem Pharmacol. 1992 Mar 3;43(5):1151–1154. doi: 10.1016/0006-2952(92)90626-t. [DOI] [PubMed] [Google Scholar]
  17. Neumann C., Sorg C. Sequential expression of functions during macrophage differentiation in murine bone marrow liquid cultures. Eur J Immunol. 1980 Nov;10(11):834–840. doi: 10.1002/eji.1830101107. [DOI] [PubMed] [Google Scholar]
  18. Niehörster M., Tiegs G., Schade U. F., Wendel A. In vivo evidence for protease-catalysed mechanism providing bioactive tumor necrosis factor alpha. Biochem Pharmacol. 1990 Oct 1;40(7):1601–1603. doi: 10.1016/0006-2952(90)90461-s. [DOI] [PubMed] [Google Scholar]
  19. Schade U. F., Ernst M., Reinke M., Wolter D. T. Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo. Biochem Biophys Res Commun. 1989 Mar 15;159(2):748–754. doi: 10.1016/0006-291x(89)90058-2. [DOI] [PubMed] [Google Scholar]
  20. Tiegs G., Niehörster M., Wendel A. Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice. Biochem Pharmacol. 1990 Sep 15;40(6):1317–1322. doi: 10.1016/0006-2952(90)90398-5. [DOI] [PubMed] [Google Scholar]
  21. Tiegs G., Wolter M., Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 1989 Feb 15;38(4):627–631. doi: 10.1016/0006-2952(89)90208-6. [DOI] [PubMed] [Google Scholar]
  22. Watanabe N., Neda H., Ohtusuka Y., Sone H., Yamauchi N., Maeda M., Kuriyama H., Niitsu Y. Signalling pathway of tumor necrosis factor in normal and tumor cells. Cancer Immunol Immunother. 1989;28(3):157–163. doi: 10.1007/BF00204983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wendel A., Tiegs G. A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 1986 Jul 1;35(13):2115–2118. doi: 10.1016/0006-2952(86)90578-2. [DOI] [PubMed] [Google Scholar]
  24. Wendel A., Tiegs G., Werner C. Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 1987 Aug 15;36(16):2637–2639. doi: 10.1016/0006-2952(87)90544-2. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES